These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1096217)

  • 21. Appetite and weight gain in children: a double-blind trial using cyproheptadine and methandrostenolone.
    Kibel MA
    Cent Afr J Med; 1969 Oct; 15(11):229-32. PubMed ID: 4901745
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of Peritol in stimulating appetite and promoting weight gain.
    Irsy G; Szatlóczky E
    Ther Hung; 1977; 25(3):115-21. PubMed ID: 929477
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on mechanism of cyproheptadine-induced weight gain in human subjects.
    Stiel JN; Liddle GW; Lacy WW
    Metabolism; 1970 Mar; 19(3):192-200. PubMed ID: 4906363
    [No Abstract]   [Full Text] [Related]  

  • 24. [On the clinical use of cyproheptadine as an anti-anorexic agent and its effects on the nutritional state].
    Martino A; Musella U; Ruffolo A
    Minerva Med; 1971 May; 62(38):1941-6. PubMed ID: 5281062
    [No Abstract]   [Full Text] [Related]  

  • 25. Intense sweeteners, food intake, and the weight of a body of evidence.
    Renwick AG
    Physiol Behav; 1994 Jan; 55(1):139-43. PubMed ID: 8140158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects.
    McGuirk J; Silverstone T
    Int J Obes; 1990 Apr; 14(4):361-72. PubMed ID: 2361813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia.
    Kardinal CG; Loprinzi CL; Schaid DJ; Hass AC; Dose AM; Athmann LM; Mailliard JA; McCormack GW; Gerstner JB; Schray MF
    Cancer; 1990 Jun; 65(12):2657-62. PubMed ID: 2187585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of the appetite and body weight increasing effect of cyproheptadine. 3. Changes in lipid metabolism].
    Mertz DP; Klöpfer M
    Klin Wochenschr; 1969 Nov; 47(22):1197-200. PubMed ID: 5376915
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanisof the appetite and body weight increasing effect of cyproheptadine. II. Changes in carbohydrate metabolism].
    Mertz DP; Stelzer M
    Klin Wochenschr; 1969 Nov; 47(22):1194-7. PubMed ID: 5382012
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of cyproheptadine on serum leptin levels.
    Calka O; Metin A; Dülger H; Erkoç R
    Adv Ther; 2005; 22(5):424-8. PubMed ID: 16418149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Weight increase due to cyproheptadine].
    Lax I; Avondo R
    Minerva Pediatr; 1971 Jul; 23(28):1201-5. PubMed ID: 5097696
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cyproheptadine: an anthihistaminic and antiserotonin drug with effect on body weight. Preliminary communication].
    Francini F; Santana JG; Kitrosen J
    Prensa Med Argent; 1967 Jun; 54(18):826-8. PubMed ID: 5614113
    [No Abstract]   [Full Text] [Related]  

  • 33. Reduction of negative alliesthesia for sweet gustatory stimuli by cyproheptadine, a serotonin antagonist.
    Fantino M; Brondel L; Swiergiel AH; Lebec O
    Life Sci; 1990; 46(19):1381-7. PubMed ID: 2345485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ineffectiveness of ceruletide to reduce food intake and body weight in obese women hospitalized for weight reduction and treated with a restricted diet. A double-blind study.
    Cavagnini F; Magella A; Danesi L; De Paolis C; Farina R; Alberetto M; Calderara A; Pontiroli AE
    Peptides; 1987; 8(3):455-9. PubMed ID: 3309901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopharmacology of hunger and food intake in humans.
    Silverstone T
    Pharmacol Ther; 1982; 19(3):417-34. PubMed ID: 6765183
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute administration of capsaicin increases resting energy expenditure in young obese subjects without affecting energy intake, appetite, and circulating levels of orexigenic/anorexigenic peptides.
    Rigamonti AE; Casnici C; Marelli O; De Col A; Tamini S; Lucchetti E; Tringali G; De Micheli R; Abbruzzese L; Bortolotti M; Cella SG; Sartorio A
    Nutr Res; 2018 Apr; 52():71-79. PubMed ID: 29530622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of cyproheptadine on food consumption in the fasted rat.
    Baxter MG; Miller AA; Soroko FE
    Br J Pharmacol; 1970 May; 39(1):229P-230P. PubMed ID: 5420121
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of histamine-induced pruritus by three antihistaminic drugs.
    Rhoades RB; Leifer KN; Cohan R; Wittig HJ
    J Allergy Clin Immunol; 1975 Mar; 55(3):180-5. PubMed ID: 234488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary acquired cold urticaria. Double-blind comparative study of treatment with cyproheptadine, chlorpheniramine, and placebo.
    Wanderer AA; St Pierre JP; Ellis EF
    Arch Dermatol; 1977 Oct; 113(10):1375-7. PubMed ID: 334082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial.
    Smith SR; De Jonge L; Volaufova J; Li Y; Xie H; Bray GA
    Metabolism; 2005 Jan; 54(1):24-32. PubMed ID: 15562376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.